Scancell CEO hails “exciting” high response rate to melanoma treatment
–News Direct– Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on the initial phase of the clinical stage…